Innovation System Transformation - The Case of the Japanese Pharmaceutical Industry -
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In the pharmaceutical and most industries, innovations are through the interaction of many organizations and institutions, which is referred to as the innovation system. Recently, the innovation system in the Japanese pharmaceutical industry has undergone structural transformations because of the changing environment caused by global competition. Although some studies have explored the features, strengths, and weaknesses of the innovation system, only a few studies have investigated how the innovation system transforms. The purpose of this study is to examine the direction of the transformations that have occurred in the innovation system in the Japanese pharmaceutical industry. This study provides the direction of future change in the innovation system from three aspects, inter-organizational relations, industrial agglomerations, and government involvement in innovation systems.
Abstract
In the pharmaceutical and most industries, innovations are through the interaction of many organizations and institutions, which is referred to as the innovation system. Recently, the innovation system in the Japanese pharmaceutical industry has undergone structural transformations because of the changing environment caused by global competition. Although some studies have explored the features, strengths, and weaknesses of the innovation system, only a few studies have investigated how the innovation system transforms. The purpose of this study is to examine the direction of the transformations that have occurred in the innovation system in the Japanese pharmaceutical industry. This study provides the direction of future change in the innovation system from three aspects, inter-organizational relations, industrial agglomerations, and government involvement in innovation systems.
참고문헌 (10)
- Chesbrough, H.W., "Open Innovation: The New Imperative for Creating and Profiting from Technology" (2003), Harvard Business Press
- Cooke, P, "Regional innovation systems : Competitive regulation in the new Europe", Geoforum, 23(3), pp.365~382 (1992)
- Edquist, C., "Systems of Innovation: Technologies, Institutions and Organizations" (1997), Pinter
- Freeman, C., "Technology Policy and Economic Performance: Lessons from Japan" (1987), Pinter
- Kneller, R, "Autarkic drug discovery in Japanese pharmaceutical companies : insights into national differences in industrial innovation", Research Policy, 32(10), pp.1805~1827 (2003)
- Lundvall, B. -Å., "Technical Change and Economic Theory" (1988), Pinter
- Lundvall, B.-Å., "Towards a Theory of Innovation and Interactive Learning" (1992), Pinter
- Marcello, R., "Executing an open innovation model: Cooperation is key to competition for biopharmaceutical companies" (2015), Deloitte Center for Health Solutions
- Nelson, R., "National Systems of Innovation: A Comparative Study" (1993), Oxford University Press
- Alliance strategy and performance of major pharmaceutical farms in Japan, US and Europe, "Takatori, T.", OPIR, ~, pp.OPIR working paper, (48) (2009)